Results 161 to 170 of about 540,208 (312)
Objective To support high‐quality, patient‐centered care for systemic lupus erythematosus (SLE), the American College of Rheumatology (ACR) developed evidence‐based measures incorporating clinical and patient‐reported outcome measures (PROMs). Using the Consolidated Framework for Implementation Research (CFIR), we conducted semistructured interviews ...
Catherine Nasrallah +13 more
wiley +1 more source
Prevalence and Severity of Sleep Disorders in Patients With Mycosis Fungoides: A Case-Control Study
Ahmad Vafaeian +6 more
doaj +1 more source
Autoimmune Diseases and Mycobacterial Infection. [PDF]
Chorbajian A +10 more
europepmc +1 more source
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli +10 more
wiley +1 more source
Gut Microbiota and Autoimmune Diseases: The Therapeutic Potential of Probiotics. [PDF]
Domagała A, Kiecka A.
europepmc +1 more source
High-dose Cyclophosphamide Without Stem Cell Rescue in Autoimmune Diseases: A Systematic Review
High-dose cyclophosphamide without stem cell rescue is a radical therapy for refractory autoimmune diseases. The objective was to review the results of high-dose cyclophosphamide without stem cell rescue in autoimmune diseases. PubMed, Scielo, and Embase
Jozélio Freire de Carvalho +1 more
core +1 more source
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Autoimmune diseases in patients with different PCOS phenotypes. [PDF]
Robeva R +3 more
europepmc +1 more source
Objective This research article aims to describe the prevalence, associations, and health‐related quality of life (HRQoL) impact of mucocutaneous features of systemic lupus erythematosus (SLE). Methods Data from the Asia‐Pacific Lupus Collaboration cohort were analyzed (2013–2021).
Amanda M. Saracino +42 more
wiley +1 more source
Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity
Soheil Tavakolpour +4 more
doaj +1 more source

